Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Therapeutic Advances in Medical Oncology|July 27, 2011
Predictive and prognostic molecular markers for cancer medicineSunali Mehta, Andrew Shelling, Anita Muthukaruppan, et al.The Biochemical Journal|December 11, 2012
YB-1: oncoprotein, prognostic marker and therapeutic target?Annette Lasham, Cristin G Print, Adele G Woolley, et al.Oncogene|September 15, 2005
Y-box factor YB1 controls p53 apoptotic functionCraig Homer, Deborah A Knight, Lynne Hananeia, et al.Nucleic Acids Research|November 28, 2009
A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probeAnnette Lasham, Mike Herbert, Natacha Coppieters 't Wallant, et al.Oncogene|May 14, 2003
Nuclear localization of Y-box factor YB1 requires wild-type p53You Fang Zhang, Craig Homer, Sara J Edwards, et al.The Journal of Biological Chemistry|July 2, 2003
The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressorAnnette Lasham, Stephanie Moloney, Tracy Hale, et al.Cancers|March 28, 2020
Accessing a New Dimension in TP53 Biology: Multiplex Long Amplicon Digital PCR to Specifically Detect and Quantitate Individual TP53 TranscriptsAnnette Lasham, Peter Tsai, Sandra J Fitzgerald, et al.Pathology|April 9, 2024
Combining TP53 mutation and isoform has the potential to improve clinical practiceSankalita Ray Das, Brett Delahunt, Annette Lasham, et al.The New Zealand Medical Journal|October 27, 2017
Gene expression profiling of breast tumours from New Zealand patientsAnita Muthukaruppan, Annette Lasham, Cherie Blenkiron, et al.Acta Pharmaceutica Sinica. B|October 26, 2019
Orthogonal assays for the identification of inhibitors of the single-stranded nucleic acid binding protein YB-1AlexanderJ Trevarton, Yan Zhou, Dehua Yang, et al.Pageof 4